A Novel Polymorphism in the Promoter of the Gene Is Associated with Susceptibility to Coronary Artery Disease

Overview

Journal Dis Markers

Publisher Wiley

Specialty Biochemistry

Date 2018 Feb 28

PMID 29484037

Citations 19

Authors

Svetlana Sirotina

Irina Ponomarenko

Alexander Kharchenko

Marina Bykanova

Anna Bocharova

Kseniya Vagaytseva

Vadim Stepanov

Mikhail Churnosov

Maria Solodilova

Alexey Polonikov

Affiliations

Soon will be listed here.

Abstract

Enzymes CYP4A11 and CYP4F2 are involved in biosynthesis of vasoactive 20-hydroxyeicosatetraenoic acid and may contribute to pathogenesis of coronary artery disease (CAD). We investigated whether polymorphisms of the and genes are associated with the risk of CAD in Russian population. DNA samples from 1323 unrelated subjects (637 angiographically confirmed CAD patients and 686 age- and sex-matched healthy individuals) were genotyped for polymorphisms rs3890011, rs9332978, and rs9333029 of and rs3093098 and rs1558139 of by using the Mass-ARRAY 4 system. SNPs rs3890011 and rs9332978 of were associated with increased risk of CAD in women: OR = 1.26, 95% CI: 1.02-1.57, = 0.004, and = 0.01 and OR = 1.45, 95% CI: 1.13-1.87, = 0.004, and = 0.01, respectively. Haplotype G-C-A of was associated with increased risk of CAD (adjusted OR = 1.41, 95% CI: 1.12-1.78, and = 0.0036). Epistatic interactions were found between rs9332978 of and rs1558139 of ( = 0.025). In silico analysis allowed identifying that SNP rs9332978 is located at a binding site for multiple transcription factors; many of them are known to regulate the pathways involved in the pathogenesis of CAD. This is the first study in Europeans that reported association between polymorphism rs9332978 of and susceptibility to coronary artery disease.

Citing Articles

The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review.

Leahy C, Osborne N, Shirota L, Rote P, Lee Y, Song B Biochem Pharmacol. 2024; 228:116241.

PMID: 38697309 PMC: 11774579. DOI: 10.1016/j.bcp.2024.116241.

Obesity-Dependent Association of the rs10454142 with Breast Cancer.

Ponomarenko I, Pasenov K, Churnosova M, Sorokina I, Aristova I, Churnosov V Biomedicines. 2024; 12(4).

PMID: 38672173 PMC: 11048332. DOI: 10.3390/biomedicines12040818.

Cytochrome P450 Family and Haplotype Mapping and Association with Hepatic Gene Expression and Vitamin K Hydroxylation Activity.

Alade A, Claw K, McDonald M, Prasad B, Rettie A, Thummel K ACS Pharmacol Transl Sci. 2024; 7(3):716-732.

PMID: 38481683 PMC: 10928895. DOI: 10.1021/acsptsci.3c00287.

Novel polymorphisms in CYP4A22 associated with susceptibility to coronary heart disease.

Huang K, Ma T, Li Q, Zhong Z, Zhou Y, Zhang W BMC Med Genomics. 2024; 17(1):66.

PMID: 38438909 PMC: 10913669. DOI: 10.1186/s12920-024-01833-7.

Polymorphism rs143384 GDF5 reduces the risk of knee osteoarthritis development in obese individuals and increases the disease risk in non-obese population.

Novakov V, Novakova O, Churnosova M, Aristova I, Ponomarenko M, Reshetnikova Y Arthroplasty. 2024; 6(1):12.

PMID: 38424630 PMC: 10905832. DOI: 10.1186/s42836-023-00229-9.

References

Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A . Haplotype-based case-control study of CYP4A11 gene and myocardial infarction. Hereditas. 2012; 149(3):91-8. DOI: 10.1111/j.1601-5223.2012.02247.x. View

Fitzpatrick F, Murphy R . Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. Pharmacol Rev. 1988; 40(4):229-41. View

Roman R . P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002; 82(1):131-85. DOI: 10.1152/physrev.00021.2001. View

Ward N, Tsai I, Barden A, Bockxmeer F, Puddey I, Hodgson J . A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. Hypertension. 2008; 51(5):1393-8. DOI: 10.1161/HYPERTENSIONAHA.107.104463. View

Sole X, Guino E, Valls J, Iniesta R, Moreno V . SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006; 22(15):1928-9. DOI: 10.1093/bioinformatics/btl268. View

Mayer B, Lieb W, Gotz A, Konig I, Kauschen L, Linsel-Nitschke P . Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction. J Hypertens. 2006; 24(10):1965-70. DOI: 10.1097/01.hjh.0000244944.34546.8e. View

Akira S, Isshiki H, Sugita T, TANABE O, Kinoshita S, Nishio Y . A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990; 9(6):1897-906. PMC: 551896. DOI: 10.1002/j.1460-2075.1990.tb08316.x. View

Spiecker M, Liao J . Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch Biochem Biophys. 2004; 433(2):413-20. DOI: 10.1016/j.abb.2004.10.009. View

Gainer J, Bellamine A, Dawson E, Womble K, Grant S, Wang Y . Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation. 2004; 111(1):63-9. DOI: 10.1161/01.CIR.0000151309.82473.59. View

10.

Spector A, Kim H . Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism. Biochim Biophys Acta. 2014; 1851(4):356-65. PMC: 4314516. DOI: 10.1016/j.bbalip.2014.07.020. View

11.

Wu C, Gupta T, Garcia V, Ding Y, Schwartzman M . 20-HETE and blood pressure regulation: clinical implications. Cardiol Rev. 2013; 22(1):1-12. PMC: 4292790. DOI: 10.1097/CRD.0b013e3182961659. View

12.

Guo L, Du Y, Chang S, Zhang K, Wang J . rSNPBase: a database for curated regulatory SNPs. Nucleic Acids Res. 2013; 42(Database issue):D1033-9. PMC: 3964952. DOI: 10.1093/nar/gkt1167. View

13.

Polonikov A, Ushachev D, Ivanov V, Churnosov M, Freidin M, Ataman A . Altered erythrocyte membrane protein composition mirrors pleiotropic effects of hypertension susceptibility genes and disease pathogenesis. J Hypertens. 2015; 33(11):2265-77. DOI: 10.1097/HJH.0000000000000699. View

14.

Poli V . The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem. 1998; 273(45):29279-82. DOI: 10.1074/jbc.273.45.29279. View

15.

Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A . Haplotype-based case-control study of the human CYP4F2 gene and essential hypertension in Japanese subjects. Hypertens Res. 2008; 31(9):1719-26. DOI: 10.1291/hypres.31.1719. View

16.

Arnett D, Baird A, Barkley R, Basson C, Boerwinkle E, Ganesh S . Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and.... Circulation. 2007; 115(22):2878-901. DOI: 10.1161/CIRCULATIONAHA.107.183679. View

17.

Laganiere J, Deblois G, Lefebvre C, Bataille A, Robert F, Giguere V . From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A. 2005; 102(33):11651-6. PMC: 1183449. DOI: 10.1073/pnas.0505575102. View

18.

Zhang R, Lu J, Hu C, Wang C, Yu W, Ma X . A common polymorphism of CYP4A11 is associated with blood pressure in a Chinese population. Hypertens Res. 2011; 34(5):645-8. DOI: 10.1038/hr.2011.8. View

19.

Roger V, Go A, Lloyd-Jones D, Benjamin E, Berry J, Borden W . Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2011; 125(1):e2-e220. PMC: 4440543. DOI: 10.1161/CIR.0b013e31823ac046. View

20.

Nikpay M, Goel A, Won H, Hall L, Willenborg C, Kanoni S . A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015; 47(10):1121-1130. PMC: 4589895. DOI: 10.1038/ng.3396. View